NEA Management Company’s Xenon Pharmaceuticals XENE Stock Holding History

NEA Management Company’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-992,107	Closed	-$15.2M	–	62
2021 Q3	$15.2M	Hold	992,107	–	–	0.18%	45
2021 Q2	$18.5M	Hold	992,107	–	–	0.24%	43
2021 Q1	$17.8M	Hold	992,107	–	–	0.4%	42
2020 Q4	$15.3M	Hold	992,107	–	–	0.4%	39
2020 Q3	$11M	Hold	992,107	–	–	0.47%	38
2020 Q2	$12.4M	Hold	992,107	–	–	0.5%	30
2020 Q1	$11.3M	Hold	992,107	–	–	0.59%	27
2019 Q4	$13M	Buy	992,107 +389,444	+65%	+$4.1M	0.62%	27
2019 Q3	$5.43M	Buy	602,663 +419,909	+230%	+$3.97M	0.45%	32
2019 Q2	$1.8M	Buy	+182,754	New	+$1.75M	0.13%	40

Other funds holding XENE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

NEA Management Company's XENE Position: Q4 2021 in Review

NEA Management Company sold out of Xenon Pharmaceuticals (XENE) in Q4 2021, closing a stake of 992,107 shares — an estimated $15.2M sold.

NEA Management Company first reported a position in XENE in Q2 2019 and held it in 10 quarters. The position peaked at $18.5M in Q2 2021. 130 funds tracked by Wall St. Rank hold XENE as of Q4 2021.

NEA Management Company reported no remaining Xenon Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
NEA Management Company sold 992,107 Xenon Pharmaceuticals shares in Q4 2021, an estimated $15.2M.
NEA Management Company first reported a position in Xenon Pharmaceuticals in Q2 2019 and held it in 10 quarters.
NEA Management Company's Xenon Pharmaceuticals position peaked at $18.5M in Q2 2021.
130 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2021.

Based on NEA Management Company's 13F filing for Q4 2021, filed 14 Feb 2022.